Ayr Wellness Inc. (CNSX: AYR.A)
Health Care · Pharmaceuticals · US
CA$—
— today · — 1Y
Ayr Wellness Inc. (CNSX: AYR.A) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $13.21M and employs 2,440 people.
trading between 0.12 and 0.39.
Tweenvest scores Ayr Wellness Inc. across four factors: quality 47/100, value 52/100, growth 75/100. Its strongest factor is growth.
AYR.A price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.21M
- Revenue (TTM)
- $452.90M
- P/E
- —
- EPS
- -2.69
- Dividend yield
- —
- Beta (5Y)
- 1.02
- 52-week high
- CA$0.39
- 52-week low
- CA$0.12
- Avg volume (3M)
- —
- Shares outstanding
- 116.77M
- Employees
- 2,440
- Next earnings
- —
About Ayr Wellness Inc.
Ayr Wellness Inc. is a vertically integrated, multi-state cannabis company that handles the cultivation, manufacturing, and retail sales of its own branded cannabis products. Their diverse product line includes items such as concentrates, edibles, and vaporizers. Beyond its core operations, the company also offers administrative, consulting, and operational support services to other licensed cannabis businesses. As of November 1, 2022, Ayr Wellness Inc. was managing 52 dispensaries. The company, which was initially incorporated as Ayr Strategies Inc. in 2017, officially adopted its current name, Ayr Wellness Inc., in February 2021. Its corporate headquarters are situated in Miami, Florida.
- ISIN
- CA05475P1099
- Founded
- 2017
- Listed since
- Aug 20, 2019
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.